Table 2: Risk factors for underuse of anticoagulants in patients with moderate-to-high risk NVAF and patients with VAF.

Risk factorsNVAFVAF
OR95% CIp-ValueOR95% CIp-Value

Age (per 10 years)1.122(1.040, 1.210)0.0031.517(1.277, 1.802)<0.001
SBP (per 10 mmHg)1.102(1.051, 1.155)<0.0010.855(0.744, 0.982)0.026
DBP (per 10 mmHg)1.356(1.106, 1.662)0.003
Regions (vs middle)
 Northeast1.9001.164, 3.1010.010
 East1.4381.176, 1.760<0.001
 West1.2700.969, 1.6650.083
Hospital level (vs tertiary)0.4200.324, 0.543<0.0010.539(0.335, 0.865)0.010
Type of AF (vs persistent/permanent)
 New-onset1.8571.412, 2.441<0.0011.978(0.975, 4.013)0.059
 Paroxysmal1.7681.470, 2.128<0.0011.761(1.072, 2.895)0.026
Dyslipidemia0.7180.591, 0.8730.001
History of CAD0.198(0.061, 0.644)0.007
History of thromboembolism0.6400.520, 0.789<0.001
Antiarrhythmic treatment0.3590.271, 0.475<0.0010.461(0.258, 0.823)0.009

AF: atrial fibrillation; CAD: coronary artery disease; CI: confidence interval; DBP: diastolic blood pressure; NVAF: non-valvular atrial fibrillation; OR: odds ratio; SBP: systolic blood pressure; VAF: valvular atrial fibrillation.